<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00766844</url>
  </required_header>
  <id_info>
    <org_study_id>UIC 2007-0899</org_study_id>
    <secondary_id>FDA IDE G060177/S001</secondary_id>
    <nct_id>NCT00766844</nct_id>
  </id_info>
  <brief_title>Cervical Spinal Cord Stimulation for the Prevention of Cerebral Vasospasm</brief_title>
  <official_title>Cervical Spinal Cord Stimulation for the Prevention of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage Using MTS Trial System 3510</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konstantin V. Slavin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigates safety, feasibility and effectiveness of cervical spinal cord
      stimulation (SCS) in prevention of cerebral arterial vasospasm following aneurysmal
      subarachnoid hemorrhage (aSAH).

      It is postulated that 2 week long stimulation of the cervical spinal cord using an implanted
      epidural electrode will prevent or decrease severity of cerebral arterial vasospasm following
      aSAH.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Continuous stimulation of the cervical spinal cord for 14 days after electrode implantation
      (within 3 days after aneurysmal subarachnoid hemorrhage). The single-arm single-institution
      non-randomized prospective study evaluates effects of cervical spinal cord stimulation on
      prevention of cerebral arterial vasospasm.

      The patients are followed for 12 months after completion of stimulation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevention of cerebral vasospasm</measure>
    <time_frame>14-17 days after aSAH</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Any complication of spinal cord stimulation</measure>
    <time_frame>up to 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Aneurysmal Subarachnoid Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spinal cord stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>spinal cord stimulation</intervention_name>
    <description>electrode is inserted into cervical epidural space for continuous spinal cord stimulation</description>
    <arm_group_label>Active</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-65

          -  Subarachnoid hemorrhage (SAH) within 72 hours

          -  Ruptured aneurysm confirmed by angiography of CT angiography

          -  Fisher grade 2-4

          -  Hunt &amp; Hess grade 2-4

          -  Aneurysm is secured

          -  Ability to obtain informed consent

        Exclusion Criteria:

          -  Pregnancy

          -  Allergy to IV contrast or to any component of SCS system

          -  Non-aneurysmal SAH

          -  Previous cervical spine surgery or any anomaly of cervical spine that would prevent
             electrode insertion

          -  Coagulopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Konstantin V Slavin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Illinois Medical Center in Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2008</study_first_submitted>
  <study_first_submitted_qc>October 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2008</study_first_posted>
  <last_update_submitted>January 21, 2013</last_update_submitted>
  <last_update_submitted_qc>January 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Konstantin V. Slavin</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>vasospasm</keyword>
  <keyword>spinal cord stimulation</keyword>
  <keyword>aneurysm</keyword>
  <keyword>subarachnoid hemorrhage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Vasospasm, Intracranial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

